sa¹ú¼Ê´«Ã½¹ÙÍøÍøÒ³Èë¿Ú

Summary: In this webinar, learn more about enabling micronization of potent and highly potent compounds across the different stages of oral drug development

Summary: ​Learn more about how the transition from early to late phase of a small molecule program plays a pivotal role in a program’s ultimate success.

Summary: Molecules that are limited by a slow onset of action, a suboptimal side-effect profile, or a complicated administration process, may be good candidates for adaptation to a unit- or...

Summary: Experts will share how dissolution tools and PBPK modeling can help evaluate whether a molecule is suitable for controlled release applications.

Summary: Experts use case studies to demonstrate how the right guidance, at the right time, can help drug developers create better treatments.

Summary: API-sparing development techniques and identification of the appropriate scalable formulation technology to improve drug solubility and enhance oral bioavailability.

Summary: In this webinar, an academic expert will discuss optimal design space parameters involved in developing spray dried dispersion of poorly soluble drugs for oral and vaccine delivery.

Summary: sa¹ú¼Ê´«Ã½¹ÙÍøÍøÒ³Èë¿ÚCEO Johh Chiminski discusses how the pandemic has made us question how the future of pharma manufacturing will be altered post Covid-19.

Summary: This webinar aims to provide clarity on the types of molecules suitable for an ODT format as well as the regulatory pathways for new and established therapies.

Summary: This webinar provides an overview of co-amorphous research and its recent findings, particularly, the impact of low molecular weight excipient on developability, stability and solubility.